Arkolith/Insider Trading/CEMI/Form 4

Eberly Richard

See Remarks, DirectorCHEMBIO DIAGNOSTICS, INC. (CEMI) · full profile →Form 4 · filed May 1, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
20
11 non-derivative · 9 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 26, 2023Tender(U)51K$0.45$23K0
Apr 26, 2023Tender(U)242K$0.45$109K0
Mar 16, 2023Tax withholding(F)28K$0.33$9K242K
Mar 16, 2023Option exercise(M)78K——270K
Mar 15, 2023Option exercise(M)39K——206K
Mar 15, 2023Tax withholding(F)14K$0.39$5K192K
Mar 11, 2023Tax withholding(F)52K$0.44$23K167K
Mar 11, 2023Option exercise(M)144K——219K
Mar 16, 2022Tax withholding(F)41K$0.70$29K75K
Mar 16, 2022Option exercise(M)78K——117K
Mar 15, 2022Option exercise(M)39K——39K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 27, 2023Disposed to issuer(D)143K——0
Apr 27, 2023Disposed to issuer(D)321K——0
Apr 27, 2023Disposed to issuer(D)690K——0
Apr 26, 2023Disposed to issuer(D)327K——0
Mar 16, 2023Option exercise(M)78K—$00
Mar 15, 2023Option exercise(M)39K—$039K
Mar 11, 2023Option exercise(M)144K—$0288K
Mar 16, 2022Option exercise(M)78K—$078K
Mar 15, 2022Option exercise(M)39K—$077K

Transaction Codes

U
See SEC Form 4 code table
F
Shares withheld for taxes
M
Option exercise / conversion
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001140361-23-022235) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML